UBS Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976M | Sell |
|
|||||
|
2025
Q1 | $1.3B | Buy |
|
|||||
|
2024
Q4 | $1.26B | Sell |
|
|||||
|
2024
Q3 | $1.58B | Buy |
|
|||||
|
2024
Q2 | $1.38B | Buy |
|
|||||
|
2024
Q1 | $1.33B | Buy |
|
|||||
|
2023
Q4 | $1.11B | Buy |
|
|||||
|
2023
Q3 | $1.03B | Sell |
|
|||||
|
2023
Q2 | $1.1B | Buy |
|
|||||
|
2023
Q1 | $1.19B | Buy |
|
|||||
|
2022
Q4 | $1.04B | Buy |
|
|||||
|
2022
Q3 | $913M | Sell |
|
|||||
|
2022
Q2 | $1.04B | Sell |
|
|||||
|
2022
Q1 | $1.28B | Buy |
|
|||||
|
2021
Q4 | $1.42B | Sell |
|
|||||
|
2021
Q3 | $1.31B | Sell |
|
|||||
|
2021
Q2 | $1.16B | Sell |
|
|||||
|
2021
Q1 | $1.12B | Sell |
|
|||||
|
2020
Q4 | $1.27B | Buy |
|
|||||
|
2020
Q3 | $1.17B | Sell |
|
|||||
|
2020
Q2 | $1.03B | Sell |
|
|||||
|
2020
Q1 | $868M | Sell |
|
|||||
|
2019
Q4 | $1.1B | Buy |
|
|||||
|
2019
Q3 | $972M | Sell |
|
|||||
|
2019
Q2 | $1.03B | Buy |
|
|||||
|
2019
Q1 | $894M | Sell |
|
|||||
|
2018
Q4 | $748M | Buy |
|
|||||
|
2018
Q3 | $776M | Buy |
|
|||||
|
2018
Q2 | $638M | Buy |
|
|||||
|
2018
Q1 | $621M | Buy |
|
|||||
|
2017
Q4 | $569M | Buy |
|
|||||
|
2017
Q3 | $565M | Sell |
|
|||||
|
2017
Q2 | $526M | Buy |
|
|||||
|
2017
Q1 | $454M | Buy |
|
|||||
|
2016
Q4 | $410M | Buy |
|
|||||
|
2016
Q3 | $440M | Buy |
|
|||||
|
2016
Q2 | $389M | Buy |
|
|||||
|
2016
Q1 | $356M | Buy |
|
|||||
|
2015
Q4 | $356M | Buy |
|
|||||
|
2015
Q3 | $261M | Buy |
|
|||||
|
2015
Q2 | $252M | Buy |
|
|||||
|
2015
Q1 | $211M | Buy |
|
|||||
|
2014
Q4 | $132M | Buy |
|